\-\ Texto\\:\\ \ \(0\)\
\-\ color\\ and\\ gray\\-scale\\ sonography\\ of\\ the\\ liver\\ demonstrates\\ diffusely\\ increased\\ echogenicity\\ of\\ the\\ portal\\ tracts\\,\\ secondary\\ to\\ periportal\\ fibrotic\\ changes\\.\\ \\ when\\ compared\\ to\\ the\\ prior\\ sonogram\\ from\\ 2006\\,\\ these\\ findings\\ are\\ more\\ pronounced\\.\ \(0\)\
\-\ sonographic\\ evaluation\\ of\\ the\\ kidneys\\ demonstrates\\ enlargement\\ with\\ diffusely\\ increased\\ echogenicity\\ and\\ loss\\ of\\ the\\ normal\\ corticomedullary\\ differentiation\\.\\ \\ numerous\\ microcysts\\ are\\ visualized\\ within\\ the\\ renal\\ parenchyma\\.\ \(0\)\
\-\ the\\ right\\ kidney\\ measures\\ 11\\.5\\ cm\\ in\\ length\\.\\ \\ the\\ left\\ kidney\\ measures\\ 13\\.2\\ cm\\ in\\ length\\.\\ \\ when\\ compared\\ to\\ the\\ sonogram\\ from\\ 2006\\,\\ \\ the\\ renal\\ parenchyma\\ has\\ increased\\ in\\ echotexture\\.\ \(0\)\
\-\ autosomal\\ recessive\\ polycystic\\ kidney\\ disease\ \(2\)\
\-\ autosomal\\ recessive\\ polycystic\\ disease\ \(0\)\
\-\ autosomal\\ dominant\\ polycystic\\ disease\ \(0\)\
\-\ multicystic\\ dysplastic\\ kidney\ \(3\)\
\-\ renal\\ cystic\\ dysplasia\\,\\ related\\ to\\ vesicoureteral\\ reflux\ \(0\)\
\-\ syndomes\ \(0\)\
\-\ \\	tuberous\\ sclerosis\ \(0\)\
\-\ \\	von\\ hippel\\-lindau\\ disease\ \(0\)\
\-\ \\	meckel\\-gruber\\ syndrome\ \(0\)\
\-\ cystic\\ neoplasms\ \(3\)\
\-\ \\	wilms\\ tumor\ \(0\)\
\-\ 11\\ year\\ old\\ girl\\ with\\ known\\ diagnosis\\ presenting\\ for\\ evaluation\\ of\\ liver\\ and\\ kidneys\\.\ \(1\)\
\-\ this\\ patient\\ was\\ born\\ with\\ renal\\ insufficiency\\ and\\ admitted\\ to\\ the\\ nicu\\ for\\ a\\ period\\ of\\ 45\\ \\ days\\.\\ \\ further\\ work\\-up\\ revealed\\ the\\ diagnosis\\ of\\ autosomal\\ recessive\\ polycystic\\ kidney\\ disease\\.\\ \\ \\ as\\ an\\ outpatient\\,\\ her\\ renal\\ function\\ has\\ improved\\,\\ and\\ the\\ patient\\ is\\ currently\\ being\\ treated\\ for\\ systemic\\ hypertension\\ with\\ hydrochlorothiazide\\,\\ which\\,\\ according\\ to\\ her\\ parents\\,\\ has\\ helped\\ to\\ stabilize\\ her\\ hypertension\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ polycystic\\:\\ 0\\.0927397854728979\ \(0\)\
\-\ autosomal\\:\\ 0\\.09072142042309372\ \(0\)\
\-\ recessive\\:\\ 0\\.07816547075280755\ \(0\)\
\-\ kidney\\:\\ 0\\.06904549208830298\ \(0\)\
\-\ renal\\:\\ 0\\.05888705388665297\ \(0\)\
\-\ sonogram\\:\\ 0\\.053392533490023\ \(0\)\
\-\ 2006\\:\\ 0\\.04517154243904469\ \(0\)\
\-\ echogenicity\\:\\ 0\\.04216523595220543\ \(0\)\
\-\ syndomes\\:\\ 0\\.040438157908103206\ \(0\)\
\-\ meckel\\-gruber\\:\\ 0\\.040438157908103206\ \(0\)\
\-\ diffusely\\:\\ 0\\.039593658290240676\ \(0\)\
\-\ length\\:\\ 0\\.03929283422764442\ \(0\)\
\-\ microcysts\\:\\ 0\\.03725858368535116\ \(0\)\
\-\ kidneys\\:\\ 0\\.036079967902569975\ \(0\)\
\-\ her\\:\\ 0\\.035358876034196365\ \(0\)\
\-\ hydrochlorothiazide\\:\\ 0\\.03407900946259912\ \(0\)\
\-\ measures\\:\\ 0\\.03354553325460522\ \(0\)\
\-\ parenchyma\\:\\ 0\\.033388703590758434\ \(0\)\
\-\ compared\\:\\ 0\\.03318368250184103\ \(0\)\
\-\ 13\\.2\\:\\ 0\\.03305541519051559\ \(0\)\
\-\ disease\\:\\ 0\\.03203526470678221\ \(0\)\
\-\ periportal\\:\\ 0\\.03151196456381278\ \(0\)\
\-\ hypertension\\:\\ 0\\.03090624818624026\ \(0\)\
\-\ 11\\.5\\:\\ 0\\.030899435239847076\ \(0\)\
\-\ gray\\-scale\\:\\ 0\\.030359146085459993\ \(0\)\
\-\ increased\\:\\ 0\\.028768139199077832\ \(0\)\
\-\ stabilize\\:\\ 0\\.02867233516745395\ \(0\)\
\-\ corticomedullary\\:\\ 0\\.028332390341060734\ \(0\)\
\-\ fibrotic\\:\\ 0\\.028015909279193982\ \(0\)\
\-\ helped\\:\\ 0\\.027719861017095032\ \(0\)\
\-\ liver\\:\\ 0\\.027029555145254347\ \(0\)\
\-\ multicystic\\:\\ 0\\.0269315570862388\ \(0\)\
\-\ hippel\\-lindau\\:\\ 0\\.0266962667450115\ \(0\)\
\-\ tracts\\:\\ 0\\.026259064085358635\ \(0\)\
\-\ pronounced\\:\\ 0\\.02483633505644194\ \(0\)\
\-\ echotexture\\:\\ 0\\.02483633505644194\ \(0\)\
\-\ dysplastic\\:\\ 0\\.02468592302514382\ \(0\)\
\-\ von\\:\\ 0\\.02468592302514382\ \(0\)\
\-\ nicu\\:\\ 0\\.02454028679434299\ \(0\)\
\-\ wilms\\:\\ 0\\.024262192198854757\ \(0\)\
\-\ vesicoureteral\\:\\ 0\\.02399999763995591\ \(0\)\
\-\ sonography\\:\\ 0\\.023292884429739126\ \(0\)\
\-\ parents\\:\\ 0\\.02277693037732312\ \(0\)\
\-\ evaluation\\:\\ 0\\.02277283298923677\ \(0\)\
\-\ cystic\\:\\ 0\\.022611309240841822\ \(0\)\
\-\ when\\:\\ 0\\.022452580161614732\ \(0\)\
\-\ outpatient\\:\\ 0\\.022313186721949867\ \(0\)\
\-\ work\\-up\\:\\ 0\\.02214006595138635\ \(0\)\
\-\ has\\:\\ 0\\.022083027116893736\ \(0\)\
\-\ according\\:\\ 0\\.02181227253862422\ \(0\)\
\-\ tuberous\\:\\ 0\\.02158093834767517\ \(0\)\
\-\ cm\\:\\ 0\\.021027120346944827\ \(0\)\
\-\ differentiation\\:\\ 0\\.02088458049048249\ \(0\)\
\-\ insufficiency\\:\\ 0\\.02082042341720387\ \(0\)\
\-\ portal\\:\\ 0\\.02063316656160637\ \(0\)\
\-\ born\\:\\ 0\\.020453255033380306\ \(0\)\
\-\ dominant\\:\\ 0\\.020005372145472433\ \(0\)\
\-\ neoplasms\\:\\ 0\\.019952340850054654\ \(0\)\
\-\ color\\:\\ 0\\.019133612499197827\ \(0\)\
\-\ sonographic\\:\\ 0\\.01900316325460822\ \(0\)\
\-\ systemic\\:\\ 0\\.0187528926846521\ \(0\)\
\-\ improved\\:\\ 0\\.018672414200014902\ \(0\)\
\-\ period\\:\\ 0\\.018326774579639733\ \(0\)\
\-\ reflux\\:\\ 0\\.018110018227114295\ \(0\)\
\-\ 45\\:\\ 0\\.018110018227114295\ \(0\)\
\-\ diagnosis\\:\\ 0\\.01800201220899468\ \(0\)\
\-\ 11\\:\\ 0\\.017936897456550773\ \(0\)\
\-\ numerous\\:\\ 0\\.017577577074578726\ \(0\)\
\-\ demonstrates\\:\\ 0\\.017124965152781522\ \(0\)\
\-\ admitted\\:\\ 0\\.016933735984235043\ \(0\)\
\-\ function\\:\\ 0\\.016617254922368294\ \(0\)\
\-\ related\\:\\ 0\\.01618005226271543\ \(0\)\
\-\ presenting\\:\\ 0\\.01597614509495931\ \(0\)\
\-\ visualized\\:\\ 0\\.015866661235295808\ \(0\)\
\-\ enlargement\\:\\ 0\\.015553066084794016\ \(0\)\
\-\ currently\\:\\ 0\\.015532902729413108\ \(0\)\
\-\ dysplasia\\:\\ 0\\.015472939052498646\ \(0\)\
\-\ sclerosis\\:\\ 0\\.014079427676267638\ \(0\)\
\-\ girl\\:\\ 0\\.013781547848577056\ \(0\)\
\-\ to\\:\\ 0\\.013713196142664696\ \(0\)\
\-\ being\\:\\ 0\\.01365957787523192\ \(0\)\
\-\ revealed\\:\\ 0\\.012580155458101346\ \(0\)\
\-\ further\\:\\ 0\\.012465340100001185\ \(0\)\
\-\ known\\:\\ 0\\.012403904057173485\ \(0\)\
\-\ days\\:\\ 0\\.012014102276018247\ \(0\)\
\-\ treated\\:\\ 0\\.011733260715981006\ \(0\)\
\-\ from\\:\\ 0\\.01161867626746984\ \(0\)\
\-\ loss\\:\\ 0\\.01137827602049743\ \(0\)\
\-\ changes\\:\\ 0\\.011234165028601195\ \(0\)\
\-\ syndrome\\:\\ 0\\.011210580627223127\ \(0\)\
\-\ \\,\\:\\ 0\\.011176103622273333\ \(0\)\
\-\ secondary\\:\\ 0\\.010958853057379852\ \(0\)\
\-\ are\\:\\ 0\\.010686916261739466\ \(0\)\
\-\ these\\:\\ 0\\.010201122440173578\ \(0\)\
\-\ prior\\:\\ 0\\.010064737487166806\ \(0\)\
\-\ for\\:\\ 0\\.01003359837581718\ \(0\)\
\-\ more\\:\\ 0\\.009803561051890671\ \(0\)\
\-\ tumor\\:\\ 0\\.0091386802826184\ \(0\)\
\-\ findings\\:\\ 0\\.008343288696284219\ \(0\)\
\-\ the\\:\\ 0\\.008244223399757502\ \(0\)\
\-\ patient\\:\\ 0\\.007858641568040257\ \(0\)\
\-\ within\\:\\ 0\\.007477667010945329\ \(0\)\
\-\ which\\:\\ 0\\.0073171770056997655\ \(0\)\
\-\ normal\\:\\ 0\\.006145011259628904\ \(0\)\
\-\ as\\:\\ 0\\.005929254614193247\ \(0\)\
\-\ in\\:\\ 0\\.005799044451471398\ \(0\)\
\-\ an\\:\\ 0\\.005420481028829036\ \(0\)\
\-\ was\\:\\ 0\\.004533383129420582\ \(0\)\
\-\ this\\:\\ 0\\.004408886299606115\ \(0\)\
\-\ left\\:\\ 0\\.004385803987490435\ \(0\)\
\-\ year\\:\\ 0\\.004385803987490435\ \(0\)\
\-\ right\\:\\ 0\\.0041359252711487\ \(0\)\
\-\ and\\:\\ 0\\.004128646920463726\ \(0\)\
\-\ old\\:\\ 0\\.004013461453496581\ \(0\)\
\-\ of\\:\\ 0\\.0037409477320455003\ \(0\)\
\-\ is\\:\\ 0\\.0025793154971776406\ \(0\)\
\-\ with\\:\\ 0\\.0021468656163282523\ \(0\)\
\-\ a\\:\\ 0\\.0018192651459568866\ \(0\)\
\-\ \\.\\:\\ 0\\.0017912609957376562\ \(0\)\
